These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10644909)

  • 1. Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis.
    Tam FW; Smith J; Agarwal S; Karkar AM; Morel D; Thompson EM; Pusey CD
    Nephron; 2000 Jan; 84(1):58-66. PubMed ID: 10644909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
    Karkar AM; Smith J; Pusey CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
    Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
    Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
    Han Y; Ma FY; Di Paolo J; Nikolic-Paterson DJ
    Int J Immunopathol Pharmacol; 2018; 32():2058738418783404. PubMed ID: 29923438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
    Saga D; Sakatsume M; Ogawa A; Tsubata Y; Kaneko Y; Kuroda T; Sato F; Ajiro J; Kondo D; Miida T; Narita I; Gejyo F
    Kidney Int; 2005 May; 67(5):1821-9. PubMed ID: 15840029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.
    Ogawa D; Shikata K; Matsuda M; Okada S; Wada J; Yamaguchi S; Suzuki Y; Miyasaka M; Tojo S; Makino H
    Clin Exp Immunol; 2002 Jul; 129(1):43-53. PubMed ID: 12100021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
    Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
    Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
    Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD
    J Immunol; 1999 May; 162(9):5519-27. PubMed ID: 10228033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
    Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
    J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
    Le Hir M; Haas C; Marino M; Ryffel B
    Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
    Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
    Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH; Holdsworth SR; Tipping PG
    Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.